A New OTC Pathway At Last: The Acronym Isn’t The Only Thing That’s Changed
Executive Summary
The US FDA is proposing a novel pathway to permit OTC drugs to be marketed with some additional controls to assure appropriate use, more than a decade after floating the idea. The pathway has a new name (“ACNU” not “NSURE”) and very different commercial dynamics.